How is Sanfilippo Syndrome diagnosed?

Sanfilippo Syndrome, or mucopolysaccharidosis type III (MPS III), is primarily diagnosed through specialized biochemical urine tests that detect elevated levels of heparan sulfate, followed by confirmatory genetic testing to identify specific enzyme deficiencies. Because symptoms like behavioral changes and developmental delays are non-specific, the diagnostic process often involves a multidisciplinary evaluation by metabolic specialists and clinical geneticists.

How is the diagnostic process for Sanfilippo Syndrome conducted?

The journey toward a diagnosis of Sanfilippo Syndrome is often described by families as a "diagnostic odyssey," frequently spanning several years because initial symptoms—such as recurring ear infections, sleep disturbances, or mild developmental delays—are often attributed to more common childhood conditions. The clinical suspicion usually begins when a pediatrician or neurologist notices a combination of behavioral challenges, such as profound hyperactivity or cognitive regression, alongside physical markers like coarse facial features. To confirm Sanfilippo Syndrome, physicians typically follow a structured clinical pathway: biochemical screening (urine GAG analysis) to detect excessive heparan sulfate, followed by enzyme assay testing in blood or skin cells to pinpoint the specific subtype (A, B, C, or D), and finally, genetic sequencing to identify pathogenic variants in the corresponding genes (SGSH, NAGLU, HGSNAT, or GNS).

What tests are used to confirm Sanfilippo Syndrome?

Because Sanfilippo Syndrome is a rare lysosomal storage disorder, standard blood work often appears normal, which can delay diagnosis. Definitive diagnosis requires specialized testing:

• Urine GAG Analysis: Measuring the concentration of heparan sulfate glycosaminoglycans (GAGs).


• Enzyme Activity Assay: A blood or fibroblast (skin cell) test to measure the activity levels of the four enzymes associated with the different types of Sanfilippo Syndrome.


• Molecular Genetic Testing: Comprehensive sequencing of the SGSH, NAGLU, HGSNAT, or GNS genes to confirm the specific mutation.


• Clinical Imaging: MRI scans are often utilized to assess for signs of cerebral atrophy or hydrocephalus, which are common neurological manifestations of the disease.

Which specialists are involved in diagnosing Sanfilippo Syndrome?

Given the multisystemic nature of Sanfilippo Syndrome, the diagnosis is most reliably made by a metabolic geneticist or a pediatric neurologist with expertise in neurodegenerative disorders. These specialists are trained to recognize the specific "red flags" of mucopolysaccharidosis type III that general practitioners may miss. If you suspect your child has Sanfilippo Syndrome, it is vital to seek a referral to a metabolic center of excellence. The 114 members of the DiseaseMaps community with Sanfilippo Syndrome frequently emphasize that early identification is crucial for accessing emerging clinical trials and appropriate supportive therapies.

What conditions are in the differential diagnosis?

Sanfilippo Syndrome is frequently misdiagnosed in its early stages due to its overlap with other conditions. Clinicians must perform a differential diagnosis to rule out Attention Deficit Hyperactivity Disorder (ADHD), autism spectrum disorder, or other forms of mucopolysaccharidosis. Unlike primary behavioral disorders, Sanfilippo Syndrome involves a progressive loss of previously acquired skills (developmental regression) and specific physical changes, such as thickening of the skin or joint contractures, which help distinguish it from purely psychiatric or neurodevelopmental conditions.

Next steps

• Request a referral to a metabolic geneticist or a specialized lysosomal storage disease center.


• Document your child's developmental milestones and regression timeline to provide a clear history for your specialist.


• Join the DiseaseMaps.org community to connect with other families who have navigated the diagnosis of Sanfilippo Syndrome.


• Contact patient advocacy groups like the Team Sanfilippo Foundation to learn about ongoing clinical trials and supportive care resources.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always consult with a qualified healthcare provider regarding any medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Mucopolysaccharidosis type III.


• Orphanet: Mucopolysaccharidosis type III (Sanfilippo Syndrome).


• OMIM (Online Mendelian Inheritance in Man): Entry for MPS3A, MPS3B, MPS3C, and MPS3D.


• National MPS Society: Resources for diagnosis and management of Sanfilippo Syndrome.